Latest news
Samsung Bioepis launches OPUVIZ pre-filled syringe biosimilar across Europe - Indian Pharma PostIndian Pharma Post · Mon, 10 Aug 2026 13:26:43 GMTSamsung Bioepis lines up Opuviz syringe as European aflibercept rivals multiply - The Pharma LetterThe Pharma Letter · Mon, 10 Aug 2026 12:41:14 GMTSamsung Bioepis Launches OPUVIZ™ (Aflibercept) 40 mg/mL Pre-filled Syringe Across Europe - BusinesskoreaBusinesskorea · Mon, 10 Aug 2026 06:15:19 GMT